News

Iterum Therapeutics Presented a Scientific Poster at ECCMID 2025 Highlighting the Impact of Age on Antibiotic Resistance and Efficacy of Antibiotics
Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and ...
Yahoo Finance9d
Iterum Therapeutics Presented a Scientific Poster at ECCMID 2025 Highlighting the Impact of Age on Antibiotic Resistance and Efficacy of Antibiotics
ORLYNVAH™ is a novel oral penem antibiotic for the treatment of uUTI ... or AmpC-type beta-lactamases that confer resistance to third generation cephalosporins.
manilatimes9d
Iterum Therapeutics Presented a Scientific Poster at ECCMID 2025 Highlighting the Impact of Age on Antibiotic Resistance and Efficacy of Antibiotics
This Poster will be available on the Company's website on the "Publications: Posters & Presentations” page under the "Our Science” tab. ORLYNVAH™ is a novel oral penem antibiotic for ...